BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16288885)

  • 1. Production and use of a cell permeable inhibitor of group A Paks (TAT-PID) to analyze signal transduction.
    Beeser A; Chernoff J
    Methods; 2005 Oct; 37(2):203-7. PubMed ID: 16288885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetics of Pak.
    Hofmann C; Shepelev M; Chernoff J
    J Cell Sci; 2004 Sep; 117(Pt 19):4343-54. PubMed ID: 15331659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JNK phosphorylation of paxillin, acting through the Rac1 and Cdc42 signaling cascade, mediates neurite extension in N1E-115 cells.
    Yamauchi J; Miyamoto Y; Sanbe A; Tanoue A
    Exp Cell Res; 2006 Sep; 312(15):2954-61. PubMed ID: 16814769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JNK- and Rac1-dependent induction of immediate early gene pip92 suppresses neuronal differentiation.
    Park JB; Kim EJ; Yang EJ; Seo SR; Chung KC
    J Neurochem; 2007 Jan; 100(2):555-66. PubMed ID: 17156131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reggies/flotillins regulate cytoskeletal remodeling during neuronal differentiation via CAP/ponsin and Rho GTPases.
    Langhorst MF; Jaeger FA; Mueller S; Sven Hartmann L; Luxenhofer G; Stuermer CA
    Eur J Cell Biol; 2008 Dec; 87(12):921-31. PubMed ID: 18722032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Rac/Cdc42/PAK pathway in cytoskeletal rearrangements.
    Szczepanowska J
    Acta Biochim Pol; 2009; 56(2):225-34. PubMed ID: 19513348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporally and spatially coordinated roles for Rho, Rac, Cdc42 and their effectors in growth cone guidance by a physiological electric field.
    Rajnicek AM; Foubister LE; McCaig CD
    J Cell Sci; 2006 May; 119(Pt 9):1723-35. PubMed ID: 16595546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cdc42- and Rac1-mediated endothelial lumen formation requires Pak2, Pak4 and Par3, and PKC-dependent signaling.
    Koh W; Mahan RD; Davis GE
    J Cell Sci; 2008 Apr; 121(Pt 7):989-1001. PubMed ID: 18319301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IQGAP3, a novel effector of Rac1 and Cdc42, regulates neurite outgrowth.
    Wang S; Watanabe T; Noritake J; Fukata M; Yoshimura T; Itoh N; Harada T; Nakagawa M; Matsuura Y; Arimura N; Kaibuchi K
    J Cell Sci; 2007 Feb; 120(Pt 4):567-77. PubMed ID: 17244649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scaffolding function of PAK in the PDK1-Akt pathway.
    Higuchi M; Onishi K; Kikuchi C; Gotoh Y
    Nat Cell Biol; 2008 Nov; 10(11):1356-64. PubMed ID: 18931661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho-kinase modulates the function of STEF, a Rac GEF, through its phosphorylation.
    Takefuji M; Mori K; Morita Y; Arimura N; Nishimura T; Nakayama M; Hoshino M; Iwamatsu A; Murohara T; Kaibuchi K; Amano M
    Biochem Biophys Res Commun; 2007 Apr; 355(3):788-94. PubMed ID: 17320046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EhPAK2, a novel p21-activated kinase, is required for collagen invasion and capping in Entamoeba histolytica.
    Arias-Romero LE; de Jesús Almáraz-Barrera M; Díaz-Valencia JD; Rojo-Domínguez A; Hernandez-Rivas R; Vargas M
    Mol Biochem Parasitol; 2006 Sep; 149(1):17-26. PubMed ID: 16716419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective activation by the guanine nucleotide exchange factor Don1 is a main determinant of Cdc42 signalling specificity in Ustilago maydis.
    Hlubek A; Schink KO; Mahlert M; Sandrock B; Bölker M
    Mol Microbiol; 2008 May; 68(3):615-23. PubMed ID: 18394145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated Vav2 modulates cellular invasion through Rac1 and Cdc42 in oral squamous cell carcinoma.
    Lai SY; Ziober AF; Lee MN; Cohen NA; Falls EM; Ziober BL
    Oral Oncol; 2008 Jul; 44(7):683-8. PubMed ID: 17996485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Jun kinase mediates expression of VEGF induced at transcriptional level by Rac1 and Cdc42Hs but not by RhoA.
    Saníger ML; Oya R; Macías D; Domínguez JN; Aránega A; Luque F
    J Cell Biochem; 2006 Jun; 98(3):650-60. PubMed ID: 16440308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical inhibition through conformational stabilization of Rho GTPase effectors.
    Deacon SW; Peterson JR
    Handb Exp Pharmacol; 2008; (186):431-60. PubMed ID: 18491063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular manipulation of human embryonic stem cells by TAT-PDX1 protein transduction.
    Kwon YD; Oh SK; Kim HS; Ku SY; Kim SH; Choi YM; Moon SY
    Mol Ther; 2005 Jul; 12(1):28-32. PubMed ID: 15963917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p210(Bcr-Abl) desensitizes Cdc42 GTPase signaling for SDF-1alpha-directed migration in chronic myeloid leukemia cells.
    Chang YC; Tien SC; Tien HF; Zhang H; Bokoch GM; Chang ZF
    Oncogene; 2009 Nov; 28(46):4105-15. PubMed ID: 19718053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
    Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
    Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAT-mediated protein transduction and targeted delivery of fusion proteins into mitochondria of breast cancer cells.
    Shokolenko IN; Alexeyev MF; LeDoux SP; Wilson GL
    DNA Repair (Amst); 2005 Apr; 4(4):511-8. PubMed ID: 15725631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.